Skip to Content
Full Title A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors
Protocol Number 2011-0097
Principal Investigator(s) Emily R. Winslow, MD, FACS
Division General Surgery
Status Active, not recruiting

Resveratrol has been shown to activate a protein called Notch-1. Signaling of Notch-1 has been shown to prevent tumor cell growth. Resveratrol has also been shown to prevent growth of tumors in mice. The purpose of this study is to examine the effects of resveratrol and Notch-1 on neuroendocrine tumor tissue and to examine how people with neuroendocrine tumors who take resveratrol for up to three months tolerate the product.

Other Clinical Trials in the Department of Surgery Copyright © 2017 The Board of Regents of the University of Wisconsin System